Indivior Pharmaceuticals, Inc. (INDV) Free cash flow 2022–2025
Indivior Pharmaceuticals, Inc. (INDV) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$93.0MFY2025 · since FY2022: -$9.0M → -$93.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$93.0M | -1428.6% |
| FY2024 | $7.0M | +102.3% |
| FY2023 | -$308.0M | -3322.2% |
| FY2022 | -$9.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More INDV financial trends
INDV RevenueINDV Net incomeINDV Net marginINDV Gross profitINDV Gross marginINDV Operating incomeINDV Operating marginINDV Operating cash flowINDV Capital expendituresINDV Return on equityINDV Stock buybacksINDV Dividends paidINDV Total assetsINDV Total liabilitiesINDV Shareholders’ equityINDV overview →